Sort
15,842 grants matching “pancreatic cancer”
Mechanisms of PARP Inhibitor Resistance in Ovarian Cancer
$403,288Scott H Kaufmann · Mayo Clinic Rochester · R01 · FY2015 · CA
The Exocrine and Endocrine Pancreas in Type 2 Diabetes, Pancreatitis and Cancer
$403,189Santhi Swaroop Vege · Mayo Clinic Rochester · U01 · FY2019 · DK
Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease
$403,147Matthew J. Flick · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Novel Determinants and Measures of Smokeless Tobacco Use
$403,012Dorothy K Hatsukami · University Of Minnesota · R01 · FY2012 · CA
Project 3: Inhibiting Oxidative Phosphorylation in Pancreatic Cancer
$402,801Shubham Pant · University Of Tx Md Anderson Can Ctr · P50 · FY2020 · CA
BRAVE hydrogels for interrogating cell-matrix interactions in pancreatic desmoplasia
$402,759Chien-Chi Lin · Indiana University Indianapolis · R01 · FY2019 · CA
Multifunctional immunoPET tracers for pancreatic and prostate cancer
$402,633Anna M Wu · University Of California Los Angeles · R01 · FY2014 · CA
Gene Analysis Shared Resource
$402,631Eric D Wieben · Mayo Clinic Rochester · P30 · FY2014 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$402,600Sita Kugel · Fred Hutchinson Cancer Center · R37 · FY2025 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$402,600Sita Kugel · Fred Hutchinson Cancer Research Center · R37 · FY2019 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$402,600Sita Kugel · Fred Hutchinson Cancer Research Center · R37 · FY2020 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$402,600Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
Exploring the epigenetic control of pancreatic cancer subtypes
$402,600Sita Kugel · Fred Hutchinson Cancer Center · R37 · FY2022 · CA
Development of Microbial-Based Therapies to Suppress Macropinocytosis in Kras-Driven Cancers
$402,600Edwin Manuel · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
Early Detection Biomarkers in Pancreatic Adenocarcinoma
$402,563Diane M Simeone · New York University School Of Medicine · R01 · FY2017 · CA
Early Detection Biomarkers in Pancreatic Adenocarcinoma
$402,563Diane M Simeone · New York University School Of Medicine · R01 · FY2018 · CA
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
$402,563Alec Kimmelman · New York University School Of Medicine · R01 · FY2018 · CA
Investigating the Role of Autophagy in Pancreatic Cancer Radiation Resistance
$402,563Alec Kimmelman · New York University School Of Medicine · R01 · FY2017 · CA
Targeting CXCR2 axis in Pancreatic Cancer
$402,559Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2021 · CA
Targeting CXCR2 axis in Pancreatic Cancer
$402,559Rakesh K Singh · University Of Nebraska Medical Center · R01 · FY2020 · CA
(PQ5) Mitochondria are endocellular symbionts that serve as targets for immune recognition
$402,548Andrea Facciabene · University Of Pennsylvania · R01 · FY2017 · CA
64-Bit High Performance Computing
$402,523Edward B Suh · Translational Genomics Research Inst · S10 · FY2007 · RR
Nitric Oxide as a Modifier of Oxidative Stress
$402,444David Wink · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
Development of a PET CCR2 Imaging Agent to Profile PDAC Microenvironment
$402,401Mark Myron Goodman · Emory University · R21 · FY2024 · CA
Smoking carcinogen-induced initiation of pancreatic cancer
$402,400Peter Storz · Mayo Clinic Jacksonville · R21 · FY2020 · CA